United States President Donald Trump announced on Monday that he will sign an executive order aimed at reducing prescription drug and pharmaceutical prices by 30-80%. The measure, which Trump described as “one of the most consequential” in U.S. history, is designed to bring fairness to American consumers by aligning domestic drug prices with the lowest prices globally.

“They will rise throughout the World in order to equalize and, for the first time in many years, bring FAIRNESS TO AMERICA,” Trump declared on Truth Social. He emphasized that the order will implement a 'Most Favored Nation’s Policy,' ensuring the United States pays no more than the country with the lowest prices for the same medications.

The president highlighted the anticipated impact on healthcare costs, stating the policy would lead to savings “never even thought of before” and allow the United States to save “trillions of dollars.” He reiterated the order’s significance, framing it as a landmark step toward economic fairness and healthcare reform.

Later in the day, Trump specified that drug prices would be slashed by over 50%, stating, “DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!! LOVE, DJT,” in another post on Truth Social.

The announcement immediately impacted financial markets, sending pharmaceutical stocks downward. Major companies such as Eli Lilly and Company, Pfizer Inc., and Merck & Co., Inc. experienced notable losses in premarket trading as investors reacted to the news.

The executive order is set to be signed later today, marking a significant policy shift in the administration’s ongoing efforts to lower healthcare expenses and address inflation concerns.